Horizon Pharma reported $26.63B in Market Capitalization this October of 2023, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bausch Health Companies USD 2.58B 194.9M Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Prestige Brands USD 2.97B 105M Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025